Form 4 for CCCC C4 Therapeutics, Inc.
Accepted 2021-07-06 00:00:00 ET · period of report 2021-07-01 · accession 0001209191-21-045691 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-06 | 2021-07-01 | CCCC | Crystal Adam | Chief Medical Off | S - Sale+OE | $37.98 | -15.0K | 1,700 | -90% | -$569.7K |
| D | 2021-07-06 | 2021-07-01 | CCCC | Crystal Adam | Chief Medical Off | M - OptEx | $6.50 | +15.0K | 15.0K | New | +$97.5K |
| D | 2021-07-06 | 2021-07-01 | CCCC | Crystal Adam | Chief Medical Off | M - OptEx | $0.00 | -15.0K | 142.3K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-01 | S | D | 1,700 | $38.38 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2021-07-01 | S | D | 13,300 | $37.93 | 1,700 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.33 to $38.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2021-07-01 | M | A | 15,000 | $6.50 | 15,000 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2021-07-01 | M | D | 15,000 | $0.00 | 142,292 | D | $6.50 · — to 2029-04-08 | 15,000 Common Stock | (F3) 25% of this option vested and became exercisable on February 14, 2020, with the remainder vesting in 16 equal quarterly installments thereafter. |